Do you experience migraine headaches?

Migraine Headaches are a painful problem for millions. 

Principal investigator Dr. Joel Saper of the renowned Michigan Headache & Neurological Institute (MHNI) is conducting a research study evaluating an investigational medication for the treatment of migraine headaches. To pre-qualify for this study, individuals must:

  • Be between 18 and 65 years old
  • Experience 2–6 headaches per month
  • Experience no more than 14 headache days per month

In general, research studies conducted at MHNI involve individuals who can easily travel to the Institute for regular evaluation and treatment (generally within 100 miles of Ann Arbor, Michigan).

What will happen during this study?

If you qualify, you will receive all study-related care and study medication at no cost, and your migraine condition and overall health will be closely monitored by a team of physicians and study staff. You will be asked to attend all scheduled study visits and record real-time data in an eDiary when you take your study medication.

During the first treatment period, you will treat one migraine headache with either active medication or placebo within a 4-week timeframe. After you treat your first migraine, there is also the possibility of participating in an 8-week extension treatment period with all active medication.

Taking part in this study is voluntary, and you can leave the study at any time for any reason.

Why is this study being conducted?

Migraine attacks can make it very hard to function at work or home, and may leave you feeling frustrated and hopeless if you can't get them under control. For some people, existing treatments may be ineffective or cause unpleasant side effects. As a result, researchers must constantly search for new ways to treat people with migraine headaches.

Injectable sumatriptan (6 mg) is currently an effective and FDA-approved treatment for acute migraine. In earlier trials, a lower dose of injectable sumatriptan has been shown to have a lower rate of unpleasant side effects than 6 mg injectable sumatriptan. In this study, researchers want to continue to study if injectable sumatriptan is safe and effective at a lower dosage.

What are the benefits of being in this study?

  • You will be helping others by contributing to medical research
  • You will receive study-required exams and study medication at no cost to you
  • The study medication may help relieve your symptoms
  • You may be compensated for your time and travel expenses

Any study has risks, which may include side effects related to the study medication.  Since the study medication is investigational, there may be risks and side effects that are unknown.

Ready to get started?

Please complete the following profile and a Research Nurse will contact you.

Contact Information
Description of Headache

Questions/Comments For Research Nurse:

The message area below should not be used by individuals who have a clinical circumstance under question which needs direct involvement of a medical professional. Individuals who need direct involvement of a medical professional should contact him/her directly.

Providing this information is voluntary and will be kept as private as possible. Your information will not be sold or shared with other parties without your permission or except as required by law. By submitting this form we have your permission to securely and indefinitely keep your information on file or database and to contact you for possible participation in a future research study. Your information will be removed from the database at any time, just by contacting us.